Literature DB >> 20789624

Methyldopa in Hypertension.

.   

Abstract

Entities:  

Year:  1963        PMID： 20789624      PMCID： PMC2123756     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  Treatment of severe hypertension with methyldopa.

Authors:  M HAMILTON; H KOPELMAN
Journal:  Br Med J       Date:  1963-01-19

2.  Methyldopa in the treatment of hypertension.

Authors:  R I BAYLISS; E A HARVEY-SMITH
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

3.  Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.

Authors:  L GILLESPIE; J A OATES; J R CROUT; A SJOERDSMA
Journal:  Circulation       Date:  1962-02       Impact factor: 29.690

4.  [alpha-Methyl-DOPA. Therapeutic experiences in hypertension and biochemical research on its mode of action].

Authors:  F SCHAUB; F NAGER; H SCHAER; W ZIEGLER; P LICHTLEN
Journal:  Schweiz Med Wochenschr       Date:  1962-05-19

5.  Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.

Authors:  J A OATES; L GILLESPIE; S UDENFRIEND; A SJOERDSMA
Journal:  Science       Date:  1960-06-24       Impact factor: 47.728

6.  Agranulocytosis caused by methyl dopa (Aldomet).

Authors:  G P HALLWRIGHT
Journal:  N Z Med J       Date:  1961-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.